Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
Clinical trial NCT01420874 · COMPLETED
Trial details
- NCT number
- NCT01420874
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-17
- Primary completion
- 2020-10-19
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.